You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

Two Pharma Firms in India Begin Phase IV Efficacy Trial for COVID-19 Drug, an Industrial Info Market Brief

default

Industry Segment: Market Brief | Word Count: 162 Words
Attachment: India COVID drug 0920

India's Central Drugs Standard Control Organisation (CDSCO) recently granted approval to pharmaceutical majors Cipla Limited and Optimus Pharma Limited to conduct Phase IV trials for Favipiravir, the most sought-after medicine in the treatment of mild to moderate symptoms of COVID-19.

Subscribe Now! All Fields Required...

Standard Membership - Free